2qlq
From Proteopedia
Line 20: | Line 20: | ||
==About this Structure== | ==About this Structure== | ||
- | 2QLQ is a | + | 2QLQ is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Gallus_gallus Gallus gallus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2QLQ OCA]. |
==Reference== | ==Reference== | ||
- | + | Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR., Michalczyk A, Kluter S, Rode HB, Simard JR, Grutter C, Rabiller M, Rauh D, Bioorg Med Chem. 2008 Feb 20;. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/18316192 18316192] | |
[[Category: Gallus gallus]] | [[Category: Gallus gallus]] | ||
[[Category: Non-specific protein-tyrosine kinase]] | [[Category: Non-specific protein-tyrosine kinase]] | ||
- | [[Category: | + | [[Category: Single protein]] |
- | [[Category: | + | [[Category: Pdbx_ordinal=, <PDBx:audit_author.]] |
- | + | ||
- | + | ||
[[Category: Alternative splicing]] | [[Category: Alternative splicing]] | ||
[[Category: Atp-binding]] | [[Category: Atp-binding]] | ||
Line 46: | Line 44: | ||
[[Category: Tyrosine-protein kinase]] | [[Category: Tyrosine-protein kinase]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Mar 4 | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Mar 4 20:17:46 2009'' |
Revision as of 18:17, 4 March 2009
Crystal structure of SRC kinase domain with covalent inhibitor RL3
Template:ABSTRACT PUBMED 18316192
About this Structure
2QLQ is a Single protein structure of sequence from Gallus gallus. Full crystallographic information is available from OCA.
Reference
Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR., Michalczyk A, Kluter S, Rode HB, Simard JR, Grutter C, Rabiller M, Rauh D, Bioorg Med Chem. 2008 Feb 20;. PMID:18316192[[Category: Pdbx_ordinal=, <PDBx:audit_author.]]
Page seeded by OCA on Wed Mar 4 20:17:46 2009
Categories: Gallus gallus | Non-specific protein-tyrosine kinase | Single protein | Alternative splicing | Atp-binding | Drug resistance | Irreversible inhibitor | Kovalent inhibitor | Lipoprotein | Myristate | Nucleotide-binding | Phosphorylation | Proto-oncogene | Sh2 domain | Sh3 domain | Src kinase domain | Transferase | Tyrosine-protein kinase